文献速递糖尿病

胰岛淀粉样蛋白通过破坏MHCII抗原呈递延迟NOD小鼠自身免疫性糖尿病

Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.
PubMed 文献 · Diabetologia · 2025-12-22

该研究利用单细胞RNA测序等方法,发现胰岛淀粉样蛋白形成过程中胰岛巨噬细胞的MHCII抗原呈递基因显著下调。表达人源胰淀素(hIAPP)的NOD小鼠糖尿病发病延迟,中位发病时间分别为30.3周与19.5周(p=0.016)和28.2周与18.0周(p=0.049),机制为胰腺内抗原呈递减少而非系统性自身免疫受损。

要点

  • 胰岛淀粉样蛋白形成下调胰岛巨噬细胞MHCII抗原呈递基因。
  • hIAPP转基因或敲入均延迟NOD小鼠糖尿病发病。
  • 保护机制为胰腺局部抗原呈递减少,系统性自身免疫仍完整。

核心结论

  • IAPP聚集体通过吞噬作用依赖机制降低MHCII表面表达和抗原特异性T细胞活化,从而延迟NOD小鼠糖尿病。
  • 尽管IAPP聚集体促炎,但早期淀粉样蛋白形成中的摄取破坏了β细胞自身免疫。

研究设计与样本

  • 使用单细胞RNA测序对有无淀粉样蛋白形式人胰岛淀粉样多肽(hIAPP)的小鼠胰岛驻留巨噬细胞进行无偏表型研究。
  • 在表达hIAPP的NOD小鼠和离体抗原呈递细胞中评估胰岛淀粉样蛋白在自身免疫性糖尿病和抗原呈递中的作用。

主要发现

  • 胰岛淀粉样蛋白形成期间,胰岛巨噬细胞中MHCII抗原呈递基因强烈下调。
  • 表达hIAPP转基因的NOD小鼠糖尿病延迟,中位发病30.3 vs 19.5周,p=0.016。
  • hIAPP基因敲入的生理表达也延迟NOD小鼠糖尿病,中位发病28.2 vs 18.0周,p=0.049,伴随抗原呈递和活化标志物减少及胰岛免疫细胞浸润减少。
  • 过继转移研究表明系统性自身免疫功能保持完整,hIAPP转基因小鼠的β细胞未逃避致糖尿病T细胞的免疫识别。
  • 树突状细胞与IAPP聚集体孵育降低MHCII表面表达,并通过吞噬作用依赖机制减弱抗原特异性T细胞活化。

临床怎么用

  • 提示IAPP聚集体在早期淀粉样形成阶段可能通过减少胰腺抗原呈递而延缓自身免疫性糖尿病进展。
  • 为理解1型糖尿病中胰岛淀粉样蛋白的免疫调节作用提供新视角。

局限性

  • 研究基于NOD小鼠模型,结果向人类1型糖尿病的转化需进一步验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Islet amyloid contributes to beta cell failure in type 2 diabetes through several mechanisms, one being the potent induction of local islet inflammation through activating inflammatory pathways in islet macrophages. As islet amyloid has recently been reported in pancreases of people with type 1 diabetes, and islet macrophages are thought to play a role in the pathogenesis of type 1 diabetes, we sought to understand the impact of islet amyloid on islet macrophages and beta cell autoimmunity. METHODS: We performed an unbiased phenotypic investigation of islet macrophages in the early stage of islet amyloid formation using single-cell RNA-seq of resident islet macrophages in mice with and without the amyloidogenic form of human islet amyloid polypeptide (hIAPP). The role of islet amyloid in autoimmune diabetes and antigen presentation was assessed in hIAPP-expressing NOD mice and in antigen-presenting cells ex vivo. RESULTS: MHC class II (MHCII) antigen presentation genes were strongly downregulated in islet macrophages during islet amyloid formation. NOD mice expressing an hIAPP transgene had delayed diabetes relative to littermate controls (median onset 30.3 vs 19.5 weeks, p=0.016). Likewise, physiological expression of hIAPP by genetic knockin also delayed diabetes in NOD mice relative to littermate controls (median onset 28.2 vs 18.0 weeks, p=0.049), corresponding with decreased markers of antigen presentation and activation, as well as decreased immune cell infiltration in islets. Adoptive transfer studies showed that systemic autoimmune function remained intact and beta cells from hIAPP transgenic mice did not evade immune recognition by diabetogenic T cells, collectively indicating the protection from diabetes was mediated by decreased antigen presentation in the pancreas. Consistent with this, incubation of dendritic cells with islet amyloid polypeptide (IAPP) aggregates decreased MHCII surface expression and diminished antigen-specific T cell activation through a phagocytosis-dependent mechanism. CONCLUSIONS/INTERPRETATION: Collectively, our data reveal a novel role for IAPP aggregates in decreasing MHCII antigen presentation and show that despite the well-established proinflammatory response of macrophages to IAPP aggregates, the uptake of IAPP aggregates during early amyloid formation also disrupts beta cell autoimmunity and delays diabetes in NOD mice.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Denroche HC, Ng V, Velghe J, et al. Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice. Diabetologia. 2025. PMID: 41423547. doi:10.1007/s00125-025-06622-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。